Sept 28: Adults with late-onset Pompe disease (LOPD) have a new treatment option after the FDA approved Amicus Therapeutics Pombiliti (cipaglucosidase alfa-atga) plus Opfolda (miglustat)
Beyond locations or amenities, more operators will adopt the gym-as-clinic playbook in a race to own the members healthspan journey
We encourage you to take our free assessment quiz to determine your eligibility and receive a personalized treatment plan that prioritizes your safety and health
Stephen and Drew Sinatra present another installment of their timely Pulse Check series, where they discuss vitamin D and immunity, maintaining mental health during the pandemic, the impact of plastics in our environment, answers to your questions about arrhythmias, and simple recipes to fight cooking fatigue
Batch certificates: request a certificate of analysis showing purity percentage and absence of contaminants
Reduced Fat Storage (Anti-Lipogenesis) 2